FRESEN.MED.CARE KGAA O.N.

FME XETRA Healthcare & Biotech Monde
38.97
0.85 %

Fresenius Medical Care provides products and services for individuals suffering from kidney diseases, including dialysis and other care services.

Price history of FRESEN.MED.CARE KGAA O.N.
Price history of FRESEN.MED.CARE KGAA O.N.

Performance & Momentum

6 Months 1.47 %
1 Year 19.14 %
3 Years 1.14 %
5 Years 34.27 %

Strategic Analysis

FRESEN.MED.CARE KGAA O.N. • 2026

Fresenius Medical Care is a global company specialized in the treatment of kidney disease, with a business model combining equipment, consumables and dialysis services. Its positioning is based on a defensive and recurring model, supported by structural medical needs, which gives it greater visibility than many more cyclical healthcare stocks.

Strengths
  • Exposure to durable, non-discretionary demand for kidney care
  • A product-service mix generating recurring revenues and a long-term relationship with patients and care centers
  • Global presence providing a broad operational base and strong medical specialization
Weaknesses
  • Profitability and value creation have historically been under pressure, with a disappointing long-term stock performance
  • Sensitivity to regulatory pressures, healthcare reimbursement dynamics and operating costs in the dialysis sector
Momentum

Momentum is moderate to weak, with an still-fragile trend despite some signs of relative stabilization in the short term. The stock remains weighed down by disappointing recent performance and an unconvincing long-term market history, suggesting a profile more suited to a turnaround bet than to an already confirmed upward trend.

Similar stocks to FRESEN.MED.CARE KGAA O.N.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone